Patient and physician perspectives on the management of inflammatory bowel disease: Role of steroids in the context of biologic therapy

被引:0
|
作者
Afzali, A. [1 ]
Armuzzi, A. [2 ]
Bouhnik, Y. [3 ,4 ]
Bressler, B. [5 ]
Hart, A. [6 ]
Rubin, D. [7 ]
Sans, M. [8 ]
Siegmund, B. [9 ]
Sninsky, D. [10 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Inflammatory Bowel Dis, Columbus, OH 43210 USA
[2] Fdn Policlin A Gemelli IRCCS Univ Cattolica, Gastroenterol, Rome, Italy
[3] INSERM, Paris, France
[4] Univ Paris, Gastroenterol, Paris, France
[5] Univ British Columbia, Gastroenterol, Vancouver, BC, Canada
[6] St Marks Hosp, Gastroenterol, London, England
[7] Univ Chicago, Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA
[8] Ctr Med Teknon, Gastroenterol, Barcelona, Spain
[9] Charite Univ Med Berlin, Gastroenterol Infectiol & Rheumatol, Berlin, Germany
[10] Digest Dis Associates, Gastroenterol, Gainesville, FL USA
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P393
引用
收藏
页码:S366 / S367
页数:2
相关论文
共 50 条
  • [1] PATIENT AND PHYSICIAN PERSPECTIVES ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE: ROLE OF STEROIDS IN THE CONTEXT OF BIOLOGIC THERAPY
    Afzali, Anita
    Armuzzi, Alessandro
    Bouhnik, Yoram
    Bressler, Brian
    Hart, Ailsa
    Rubin, David T.
    Sans, Miguel
    Siegmund, Britta
    Sninsky, Charles
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S23 - S23
  • [2] Patient and physician perspectives on the management of inflammatory bowel disease: Disease remission and durability of treatment
    Afzali, A.
    Armuzzi, A.
    Bouhnik, Y.
    Bressler, B.
    Hart, A.
    Rubin, D.
    Sans, M.
    Siegmund, B.
    Sninsky, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S424 - S424
  • [3] PATIENT AND PHYSICIAN PERSPECTIVES ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE: DISEASE REMISSION AND DURABILITY OF TREATMENT
    Afzali, Anita
    Armuzzi, Alessandro
    Bouhnik, Yoram
    Bressler, Brian
    Hart, Ailsa
    Rubin, David T.
    Sans, Miguel
    Siegmund, Britta
    Sninsky, Charles
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S663 - S663
  • [4] Diagnosis and management of latent and active tuberculosis in the context of biologic therapy in inflammatory bowel disease
    Thi, A. A.
    Bouri, S.
    Wolfson, P.
    Owen, L.
    Abbara, A.
    John, L.
    Davidson, R.
    Hart, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S299 - S300
  • [5] The Role of Dual Biologic Therapy in Inflammatory Bowel Disease
    Molly, Stone
    Margaret, Morrison
    Erin, Forster
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S20 - S20
  • [6] The Role of Early Biologic Therapy in Inflammatory Bowel Disease
    Berg, Dana Rachel
    Colombel, Jean-Frederic
    Ungaro, Ryan
    [J]. INFLAMMATORY BOWEL DISEASES, 2019, 25 (12) : 1896 - 1905
  • [7] The Role of Biologic Therapy in Inflammatory Bowel Disease - Preface
    Lichtenstein, Gary R.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2006, 35 (04) : XIII - XIV
  • [9] Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease
    Barrie, Arthur
    Regueiro, Miguel
    [J]. INFLAMMATORY BOWEL DISEASES, 2007, 13 (11) : 1424 - 1429
  • [10] Biologic Therapy in Inflammatory Bowel Disease
    Theede, Klaus
    Dahlerup, Jens Frederik
    Fallingborg, Jan
    Hvas, Christian Lodberg
    Kjeldsen, Jens
    Munck, Lars Kristian
    Nordgaard-Lassen, Inge
    [J]. DANISH MEDICAL JOURNAL, 2013, 60 (06):